Ixico (IXI) Stock Discussion | Share discussion

Ixico

IXICO plc provides medical image acquisition, management, and analysis products to support the clinical trials of pharmaceutical companies worldwide.

Industry: Pharmaceuticals & Biotechnology

Ticker	Exchange	ISIN
$IXI	LSE AIM	GB00BCLY7L40

Recent news

Carnival Net Income dropped on 442% and Revenue dropped on 73.1%

Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline

Northamber Net Income surged on 1,523%

International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%

Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%

Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%

Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%

Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%

Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%

I-Nexus Global Plc revenue dropped on 14.3%

Twit about IXI stock

Share your investment idea or question on Ixico stock:

Latest twits on Ixico (IXI)

No twits yet. Be the first to post!

Have a question about IXI? Ask and other investors will be eager to help you.

Have an idea about IXI? Share it with other investors.

Ixico stock price chart

Ixico financials

mln. £	FY2013	FY2015	FY2016

Revenue	0.010	3.115	3.268
EBITDA	-5.153	0.000	-1.856
Net income	-4.767	0.000	-2.119
CAPEX	0.001	0.000	0.024
Debt	0.000	0.000	0.000
Cash	4.492	0.000	3.120

About Ixico

IXICO plc provides medical image acquisition, management, and analysis products to support the clinical trials of pharmaceutical companies worldwide. The company